Product correctly added to cart.

discount label
LCBiot-VPWMEPAYQRFL-OH
View 3D

Biosynth logo

LCBiot-VPWMEPAYQRFL-OH

Ref. 3D-PP43120

Undefined sizeTo inquire
Estimated delivery in United States, on Monday 28 Oct 2024

Product Information

Name:
LCBiot-VPWMEPAYQRFL-OH
Synonyms:
  • LCBiot-Val-Pro-Trp-Met-Glu-Pro-Ala-Tyr-Gln-Arg-Phe-Leu-OH
Description:

Peptide LCBiot-VPWMEPAYQRFL-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using LCBiot-VPWMEPAYQRFL-OH include the following: Peptide 18-4/chlorin e6-conjugated polyhedral oligomeric silsesquioxane nanoparticles for targeted photodynamic therapy of breast cancer YJ Kim, HI Lee, JK Kim, CH Kim , YJ Kim - Colloids and Surfaces B , 2020 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S092777652030059X Design and Evaluation of Gemini Surfactant-Based Lipoplexes Modified with Cell-Binding Peptide for Targeted Gene Therapy W Mohammed-Saeid, R Soudy, R Tikoo, K Kaur - 2018 - digitalcommons.chapman.eduhttps://digitalcommons.chapman.edu/pharmacy_articles/607/ Design and evaluation of gemini surfactant-based lipoplexes modified with cell-binding peptide for targeted gene therapy in melanoma model W Mohammed-Saeid , R Soudy - of Pharmacy & , 2018 - journals.library.ualberta.cahttps://journals.library.ualberta.ca/jpps/index.php/JPPS/article/view/30010 Influence of labelling methods on biodistribution and imaging properties of radiolabelled peptides for visualisation of molecular therapeutic targets V Tolmachev , A Orlova - Current medicinal chemistry, 2010 - ingentaconnect.comhttps://www.ingentaconnect.com/content/ben/cmc/2010/00000017/00000024/art00004 Characterization and development of a peptide (p160) with affinity for neuroblastoma cells V Askoxylakis , W Mier , S Zitzmann - Journal of Nuclear , 2006 - Soc Nuclear Medhttps://jnm.snmjournals.org/content/47/6/981.short Preclinical evaluation of the breast cancer cell-binding peptide, p160 V Askoxylakis , S Zitzmann, W Mier , K Graham - Clinical cancer , 2005 - AACRhttps://aacrjournals.org/clincancerres/article-abstract/11/18/6705/185959 Characterisation and in vitro and in vivo evaluation of a breast cancer cell-and neuroblastoma cell binding peptide (p160), identified through phage display V Askoxylakis - 2007 - archiv.ub.uni-heidelberg.dehttps://archiv.ub.uni-heidelberg.de/volltextserver/7625/1/ve_Sep13_141530.pdf Design, synthesis, and validation of an in vitro platform peptide-whole cell screening assay using MTT reagent S Ahmed, K Kaur - Journal of Taibah University for Science, 2017 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1658365516300802 Breast cancer targeting peptide binds keratin 1: a new molecular marker for targeted drug delivery to breast cancer R Soudy, H Etayash , K Bahadorani - Molecular , 2017 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.molpharmaceut.6b00652 Peptides targeting HER2-positive breast cancer cells and applications in tumor imaging and delivery of chemotherapeutics PA Cavallaro, M De Santo, EL Belsito, C Longobucco - Nanomaterials, 2023 - mdpi.comhttps://www.mdpi.com/2079-4991/13/17/2476 Therapeutic cancer targeting peptides OH Aina, TC Sroka, ML Chen - Peptide Science: Original , 2002 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/bip.10257 Decoration of polymeric micelles with cancer-specific peptide ligands for active targeting of paclitaxel M Shahin, S Ahmed, K Kaur , A Lavasanifar - Biomaterials, 2011 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0142961211003590 Engineered peptides for the development of actively tumor targeted liposomal carriers of doxorubicin M Shahin, R Soudy, H El-Sikhry, JM Seubert , K Kaur - Cancer letters, 2013 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0304383512005952 Current therapeutic approaches and promising perspectives of using bioengineered peptides in fighting chemoresistance in triple-negative breast cancer M Azari, F Bahreini , VN Uversky , N Rezaei - Biochemical Pharmacology, 2023 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0006295223000503 Combinatorial discovery of tumor targeting peptides using phage display LA Landon, SL Deutscher - Journal of cellular biochemistry, 2003 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/jcb.10634 Development of Novel Peptide-Doxorubicin Conjugates for Targeting Triple-Negative Breast Cancer A Saghaeidehkordi - 2021 - search.proquest.comhttps://search.proquest.com/openview/0a7f923b82b25109d646e28de819bb53/1?pq-origsite=gscholar&cbl=18750&diss=y

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-PP43120 LCBiot-VPWMEPAYQRFL-OH

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".